2.97
price up icon4.58%   0.13
after-market 시간 외 거래: 2.93 -0.04 -1.35%
loading
전일 마감가:
$2.84
열려 있는:
$2.84
하루 거래량:
6.29M
Relative Volume:
0.96
시가총액:
$598.82M
수익:
$116.33M
순이익/손실:
$-209.25M
주가수익비율:
-1.4009
EPS:
-2.12
순현금흐름:
$-135.49M
1주 성능:
+9.59%
1개월 성능:
+12.08%
6개월 성능:
+197.18%
1년 성능:
+45.59%
1일 변동 폭
Value
$2.80
$3.01
1주일 범위
Value
$2.73
$3.11
52주 변동 폭
Value
$0.6925
$3.94

Esperion Therapeutics Inc Stock (ESPR) Company Profile

Name
명칭
Esperion Therapeutics Inc
Name
전화
734-887-3903
Name
주소
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI
Name
직원
304
Name
트위터
@esperioninc
Name
다음 수익 날짜
2025-03-04
Name
최신 SEC 제출 서류
Name
ESPR's Discussions on Twitter

ESPR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
ESPR
Esperion Therapeutics Inc
2.97 657.81M 116.33M -209.25M -135.49M -2.12
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Esperion Therapeutics Inc Stock (ESPR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-18 개시 Goldman Neutral
2024-12-17 개시 Cantor Fitzgerald Overweight
2024-06-20 다운그레이드 BofA Securities Neutral → Underperform
2024-01-03 다운그레이드 BofA Securities Buy → Neutral
2023-11-20 재개 JP Morgan Neutral
2023-08-01 업그레이드 Northland Capital Under Perform → Market Perform
2023-06-15 업그레이드 BofA Securities Underperform → Buy
2023-03-16 다운그레이드 BofA Securities Neutral → Underperform
2023-03-16 다운그레이드 Northland Capital Market Perform → Under Perform
2023-03-07 업그레이드 Credit Suisse Underperform → Neutral
2023-02-27 재개 BofA Securities Neutral
2023-02-24 업그레이드 Jefferies Hold → Buy
2023-02-03 업그레이드 Morgan Stanley Underweight → Equal-Weight
2022-08-03 다운그레이드 Credit Suisse Neutral → Underperform
2022-05-05 업그레이드 JP Morgan Underweight → Neutral
2022-03-10 개시 H.C. Wainwright Buy
2021-10-19 다운그레이드 Credit Suisse Outperform → Neutral
2021-10-14 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2021-05-05 다운그레이드 Stifel Buy → Hold
2021-04-26 재개 Credit Suisse Outperform
2021-03-11 개시 Morgan Stanley Equal-Weight
2021-02-12 다운그레이드 Jefferies Buy → Hold
2021-02-09 다운그레이드 Goldman Neutral → Sell
2021-01-15 다운그레이드 BofA Securities Buy → Neutral
2020-11-10 업그레이드 Credit Suisse Neutral → Outperform
2020-09-29 재개 JP Morgan Underweight
2020-08-11 다운그레이드 Credit Suisse Outperform → Neutral
2020-04-01 재개 BofA/Merrill Buy
2020-03-17 업그레이드 Citigroup Neutral → Buy
2020-02-24 다운그레이드 Northland Capital Outperform → Market Perform
2020-02-14 다운그레이드 Citigroup Buy → Neutral
2019-09-16 업그레이드 Goldman Sell → Neutral
2019-05-29 다운그레이드 Goldman Neutral → Sell
2019-05-06 업그레이드 BofA/Merrill Underperform → Neutral
2019-04-26 업그레이드 Goldman Sell → Neutral
2019-03-13 업그레이드 JP Morgan Underweight → Neutral
2019-01-07 재확인 Needham Strong Buy
2018-12-13 개시 Goldman Sell
2018-10-29 업그레이드 Northland Capital Market Perform → Outperform
2018-10-16 개시 BTIG Research Buy
2018-08-17 업그레이드 Citigroup Neutral → Buy
2018-07-11 다운그레이드 Northland Capital Outperform → Market Perform
2018-05-03 다운그레이드 JP Morgan Neutral → Underweight
2018-05-02 다운그레이드 BofA/Merrill Buy → Underperform
모두보기

Esperion Therapeutics Inc 주식(ESPR)의 최신 뉴스

pulisher
06:52 AM

Why analysts remain bullish on Esperion Therapeutics Inc. stockWeekly Loss Report & Real-Time Volume Analysis - newser.com

06:52 AM
pulisher
06:49 AM

Can volume confirm reversal in Esperion Therapeutics Inc.July 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com

06:49 AM
pulisher
06:44 AM

Should you wait for a breakout in Esperion Therapeutics Inc.Trade Risk Assessment & Smart Allocation Stock Tips - newser.com

06:44 AM
pulisher
06:25 AM

Is Esperion Therapeutics Inc. stock reversal real or fake2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com

06:25 AM
pulisher
05:59 AM

Multi asset correlation models including Esperion Therapeutics Inc.July 2025 Drop Watch & Growth Focused Stock Reports - newser.com

05:59 AM
pulisher
05:53 AM

Will Esperion Therapeutics Inc. stock gain from lower inflationJuly 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com

05:53 AM
pulisher
05:41 AM

Esperion Therapeutics (ESPR) to Release Quarterly Earnings on Thursday - MarketBeat

05:41 AM
pulisher
05:20 AM

Why Esperion Therapeutics Inc. stock is favored by top institutions2025 Analyst Calls & Smart Allocation Stock Reports - newser.com

05:20 AM
pulisher
05:17 AM

Can Esperion Therapeutics Inc. stock deliver surprise earnings beat2025 Technical Patterns & Safe Capital Preservation Plans - newser.com

05:17 AM
pulisher
05:02 AM

Why Esperion Therapeutics Inc. is moving todayLong Setup & Risk Controlled Swing Alerts - newser.com

05:02 AM
pulisher
04:37 AM

Will Esperion Therapeutics Inc. (0ET) stock benefit from mergersEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com

04:37 AM
pulisher
04:31 AM

Will earnings trigger a reversal in Esperion Therapeutics Inc.Weekly Trade Recap & Weekly Breakout Watchlists - newser.com

04:31 AM
pulisher
04:30 AM

Why analysts raise outlook for Esperion Therapeutics Inc. (0ET) stockMarket Activity Report & Free Technical Confirmation Trade Alerts - newser.com

04:30 AM
pulisher
02:13 AM

Relative strength of Esperion Therapeutics Inc. in sector analysisEarnings Growth Report & Risk Controlled Daily Plans - newser.com

02:13 AM
pulisher
01:34 AM

Smart tools for monitoring Esperion Therapeutics Inc.’s price action2025 Market Trends & Technical Buy Zone Confirmation - newser.com

01:34 AM
pulisher
Oct 30, 2025

How to use Fibonacci retracement on Esperion Therapeutics Inc.Portfolio Performance Report & AI Enhanced Trade Execution Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Using AI based signals to follow Esperion Therapeutics Inc.Portfolio Growth Summary & Fast Gaining Stock Strategy Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How high can Esperion Therapeutics Inc. stock go2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 01:22:55 - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Identifying reversal signals in Esperion Therapeutics Inc.Quarterly Trade Summary & Low Drawdown Trading Strategies - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Applying Elliott Wave Theory to Esperion Therapeutics Inc.Quarterly Market Review & Community Consensus Trade Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Esperion Therapeutics (NASDAQ:ESPR) Trading 7.1% HigherTime to Buy? - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

How to integrate Esperion Therapeutics Inc. into portfolio analysis toolsWeekly Volume Report & Step-by-Step Swing Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-28 23:56:41 - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET. - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

How Esperion Therapeutics Inc. stock benefits from global expansion2025 Technical Patterns & Fast Entry High Yield Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Esperion (NASDAQ: ESPR) sets Nov. 11, 2 p.m. ET KOL webinar on statin intolerance - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Will Esperion Therapeutics Inc. stock return to pre crisis levelsWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Esperion Therapeutics Inc. stock reach $100 price targetPortfolio Risk Summary & Technical Pattern Alert System - newser.com

Oct 28, 2025

Esperion Therapeutics Inc (ESPR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Esperion Therapeutics Inc 주식 (ESPR) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Looker Benjamin
General Counsel
Sep 17 '25
Sale
2.80
6,267
17,573
393,670
Koenig Sheldon L.
President and CEO
Sep 17 '25
Sale
2.79
28,427
79,254
1,518,831
Halladay Benjamin
Chief Financial Officer
Sep 17 '25
Sale
2.81
7,046
19,785
474,862
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
자본화:     |  볼륨(24시간):